首页> 美国卫生研究院文献>other >Inducing a Mode of NK-Resistance to Suppression by Stress and Surgery: a Potential Approach Based on Low Dose of Poly I-C to Reduce Postoperative Cancer Metastasis
【2h】

Inducing a Mode of NK-Resistance to Suppression by Stress and Surgery: a Potential Approach Based on Low Dose of Poly I-C to Reduce Postoperative Cancer Metastasis

机译:通过压力和手术诱导NK抵抗抑制的模式:一种基于低剂量的Poly I-C减少术后癌症转移的潜在方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Perioperative suppression of NK activity has been suggested to compromise host resistance to tumor progression. Here we sought to develop a clinically applicable pre-operative regimen to prevent immunosuppression and promotion of metastasis by stress or surgery. The synthetic ds-RNA, poly I-C, was used in vivo in F344 rats, based on its alleged in vitro ability to protect immunocytes from suppression by cAMP elevating agents. Different regimens of poly I-C were studied in controls and in rats subjected to a pharmacological stressor, swim stress, or surgical stress. Resistance to lung experimental metastasis of the syngeneic non-immunogenic MADB106 mammary adenocarcinoma was assessed. Numbers of circulating and marginating-pulmonary NK cells and their cytotoxicity against the MADB106 and YAC-1 target lines were also studied. Our findings established a regimen of repeated low-dose poly I-C administration with minimal side effects (0.2 mg/kg i.p. 5, 3, & 1 day before tumor inoculation). This regimen, while hardly affecting resistance levels in non-stressed animals, prevented all stressors from promoting metastases. These beneficial effects occurred in the presence of a primary tumor and in both sexes. Poly I-C increased the numbers of NK cells, and, on a per NK cell basis, while not increasing cytotoxicity, profoundly protected marginating-pulmonary NK cells from suppression by surgery. This study suggests a non-toxic clinically-translatable prophylactic use of poly I-C to target the critical perioperative period. By increasing the number of marginating-pulmonary NK cells, and by transforming them into a mode of resistance to immunosuppression, this approach may reduce postoperative metastasis in cancer patients.
机译:已经提出围手术期抑制NK活性会损害宿主对肿瘤进展的抵抗力。在这里,我们寻求开发一种临床上适用的术前治疗方案,以防止免疫抑制和通过压力或手术促进转移。合成的ds-RNA聚I-C被用于F344大鼠体内,因为它据称具有保护免疫细胞不受cAMP升高剂抑制的体外能力。在对照组和遭受药理压力,游泳压力或手术压力的大鼠中研究了不同的poly I-C方案。评估了同基因的非免疫原性MADB106乳腺腺癌对肺实验转移的抵抗力。还研究了循环和边缘化肺NK细胞的数目及其对MADB106和YAC-1靶细胞的细胞毒性。我们的发现建立了一种重复的低剂量多聚I-C给药方案,且副作用极小(0.2 mg / kg,在接种肿瘤前5、3和1天腹腔注射)。该方案虽然几乎不影响非应激动物的抵抗力水平,但却阻止了所有应激源促进转移。这些有益作用发生在原发性肿瘤的存在下以及男女双方。 Poly I-C增加了NK细胞的数量,并且在每个NK细胞的基础上,虽然没有增加细胞毒性,但却深刻地保护了边缘化肺NK细胞免受手术抑制。这项研究表明,以聚I-C靶向关键围手术期的无毒临床可预防性使用。通过增加边缘肺NK细胞的数量,并将其转化为对免疫抑制的抵抗方式,这种方法可以减少癌症患者的术后转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号